Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj VaccinesGlobeNewsWire • 04/19/21
Translate Bio Shares Drop After Its mRNA-Based Cystic Fibrosis Candidate Did Not Improve Lung FunctionBenzinga • 03/18/21
Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)GlobeNewsWire • 03/17/21
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidateGlobeNewsWire • 03/12/21
Translate Bio, Inc. (TBIO) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 03/04/21
Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare ConferenceGlobeNewsWire • 02/18/21
Translate Bio Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021GlobeNewsWire • 01/07/21
3 mRNA Coronavirus Vaccine Stocks to Check Out That Aren't Pfizer, BioNTech, or ModernaThe Motley Fool • 11/17/20
Translate Bio Announces Third Quarter 2020 Financial Results and Reviews Recent ProgressGlobeNewsWire • 11/05/20
Translate's Covid-Vaccine, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 10/19/20
Sanofi and Translate Bio Have a COVID-19 Vaccine Candidate Ready for Clinical TrialsThe Motley Fool • 10/15/20